ISSN: 2329-9053

Zeitschrift für Molekulare Pharmazeutik und organische Prozessforschung

Offener Zugang

Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Abstrakt

Text Mining-Based Drug Discovery in Osteoarthritis

Donghun Trepat

Osteoarthritis is a prevalent degenerative joint disease characterized by the breakdown of articular cartilage and significant pain and functional limitations. Despite its high prevalence and impact on individuals' quality of life, effective therapies for OA are limited. Text mining, a subfield of data mining, offers a powerful approach to leverage the vast amount of biomedical literature and accelerate drug discovery in OA. This journal focuses on the advancements and applications of text mining techniques in OA drug discovery, aiming to uncover novel therapeutic targets, identify drug candidates, and understand disease mechanisms. Through the integration of diverse data sources, including scientific articles, clinical trial reports, and genetic databases, text mining enables the extraction and analysis of valuable information. This approach facilitates the identification of potential targets and pathways implicated in OA pathogenesis, the repurposing of existing drugs for OA treatment, and the development of personalized treatment strategies. However, challenges such as data quality and algorithm performance should be addressed. Experimental validation is crucial to ensure the reliability of text mining-based findings. Text mining-based drug discovery in OA holds great promise for transforming the field and accelerating the development of innovative treatments for this debilitating condition.